Alkermes Plc (NASDAQ:ALKS)

62.79
Delayed Data
As of Apr 17
 -0.89 / -1.40%
Today’s Change
38.49
Today|||52-Week Range
75.17
+7.22%
Year-to-Date

Today’s Trading

Previous close63.68
Today’s open63.09
Day’s range62.09 - 63.90
Volume1,603,797
Average volume (3 months)1,438,856
Market cap$9.3B
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)-229.95%
Earnings growth (this year)-211.78%
Earnings growth (next 5 years)+43.63%
Revenue growth (last year)+7.20%
P/E ratioNM
Price/Sales13.75
Price/Book6.63

Competitors

 Today’s
change
Today’s
% change
MDVNMedivation Inc-3.11-2.38%
UTHRUnited Therapeutics ...-2.72-1.45%
RDYDr.Reddy's Laborator...-0.40-0.68%
JAZZJazz Pharmaceuticals...-2.74-1.44%
Data as of 4:02pm ET, 04/17/2015

Financials

Next reporting dateApril 29, 2015
EPS forecast (this quarter)-$0.04
Annual revenue (last year)$618.8M
Annual profit (last year)-$30.1M
Net profit margin-4.86%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Richard F. Pops
President
Shane M. Cooke
Corporate headquarters
Dublin, Dublin

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers